SitesBLAST
Comparing Ga0059261_1680 Ga0059261_1680 NAD-dependent aldehyde dehydrogenases to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
4o6rA Crystal structure of a putative aldehyde dehydrogenase from burkholderia cenocepacia
39% identity, 99% coverage: 4:466/469 of query aligns to 4:477/489 of 4o6rA
- active site: N150 (= N145), K173 (= K168), E248 (= E241), C282 (= C275), E383 (= E372), E460 (= E449)
- binding adenosine monophosphate: I146 (= I141), V147 (≠ S142), K173 (= K168), G206 (≠ V200), G210 (= G203), Q211 (≠ R204), F224 (= F217), G226 (= G219), S227 (= S220), T230 (= T223), R233 (≠ S226)
6b5hA Aldh1a2 liganded with NAD and 1-(4-cyanophenyl)-n-(3-fluorophenyl)-3- [4-(methylsulfonyl)phenyl]-1h-pyrazole-4-carboxamide (compound cm121) (see paper)
39% identity, 96% coverage: 19:466/469 of query aligns to 29:485/492 of 6b5hA
- active site: N161 (= N145), E260 (= E241), C294 (= C275), E468 (= E449)
- binding 1-(4-cyanophenyl)-N-(3-fluorophenyl)-3-[4-(methylsulfonyl)phenyl]-1H-pyrazole-4-carboxamide: V112 (vs. gap), G116 (= G102), F162 (= F146), W169 (= W153), Q284 (≠ A265), F288 (≠ G269), T295 (≠ A276), N449 (≠ A430), L451 (≠ I432), N452 (≠ S433), F457 (= F438)
- binding nicotinamide-adenine-dinucleotide: I157 (= I141), I158 (≠ S142), W160 (= W144), N161 (= N145), K184 (= K168), G217 (vs. gap), G221 (= G203), F235 (= F217), T236 (= T218), G237 (= G219), S238 (= S220), V241 (≠ T223), E260 (= E241), L261 (= L242), C294 (= C275), F393 (= F374)
6b5gA Aldh1a2 liganded with NAD and (3-ethoxythiophen-2-yl){4-[4-nitro-3- (pyrrolidin-1-yl)phenyl]piperazin-1-yl}methanone (compound 6-118) (see paper)
39% identity, 96% coverage: 19:466/469 of query aligns to 29:485/492 of 6b5gA
- active site: N161 (= N145), E260 (= E241), C294 (= C275), E468 (= E449)
- binding (3-ethoxythiophen-2-yl){4-[4-nitro-3-(pyrrolidin-1-yl)phenyl]piperazin-1-yl}methanone: F162 (= F146), L165 (≠ M149), W169 (= W153), F288 (≠ G269), C293 (≠ I274), C294 (= C275), T295 (≠ A276), N449 (≠ A430), L451 (≠ I432)
- binding nicotinamide-adenine-dinucleotide: I157 (= I141), I158 (≠ S142), P159 (= P143), W160 (= W144), N161 (= N145), M166 (≠ I150), K184 (= K168), E187 (≠ S171), G217 (vs. gap), G221 (= G203), F235 (= F217), T236 (= T218), G237 (= G219), S238 (= S220), V241 (≠ T223), E260 (= E241), L261 (= L242), C294 (= C275), E391 (= E372), F393 (= F374)
6aljA Aldh1a2 liganded with NAD and compound win18,446 (see paper)
39% identity, 96% coverage: 19:466/469 of query aligns to 29:485/492 of 6aljA
- active site: N161 (= N145), E260 (= E241), C294 (= C275), E468 (= E449)
- binding N,N'-(octane-1,8-diyl)bis(2,2-dichloroacetamide): G116 (= G102), F162 (= F146), L165 (≠ M149), M166 (≠ I150), W169 (= W153), E260 (= E241), C293 (≠ I274), C294 (= C275), L451 (≠ I432), N452 (≠ S433), A453 (≠ P434)
- binding nicotinamide-adenine-dinucleotide: I157 (= I141), I158 (≠ S142), P159 (= P143), W160 (= W144), N161 (= N145), K184 (= K168), E187 (≠ S171), G217 (vs. gap), G221 (= G203), F235 (= F217), G237 (= G219), S238 (= S220), V241 (≠ T223), Q341 (= Q322), K344 (≠ L325), E391 (= E372), F393 (= F374)
O94788 Retinal dehydrogenase 2; RALDH 2; RalDH2; Aldehyde dehydrogenase family 1 member A2; ALDH1A2; Retinaldehyde-specific dehydrogenase type 2; RALDH(II); EC 1.2.1.36 from Homo sapiens (Human) (see 6 papers)
39% identity, 96% coverage: 19:466/469 of query aligns to 55:511/518 of O94788
- A110 (= A71) to V: in dbSNP:rs35365164
- Q182 (≠ S140) to K: in DIH4; decreased retinoic acid biosynthetic process
- IPW 184:186 (≠ SPW 142:144) binding
- KPAE 210:213 (≠ KPSS 168:171) binding
- STE 264:266 (≠ STP 220:222) binding
- C320 (= C275) active site, Nucleophile
- R347 (≠ A302) to H: in DIH4; decreased expression; dbSNP:rs141245344
- V348 (= V303) to I: in dbSNP:rs4646626
- KQYNK 366:370 (≠ KQFDL 321:325) binding
- A383 (≠ G338) to T: in DIH4; uncertain significance; dbSNP:rs749124508
- E417 (= E372) binding
- E436 (≠ A391) to K: in dbSNP:rs34744827
- S461 (≠ A416) to Y: in DIH4; decreased retinoic acid biosynthetic process
Sites not aligning to the query:
- 50 E → G: in dbSNP:rs34266719
Q63639 Retinal dehydrogenase 2; RALDH 2; RalDH2; Aldehyde dehydrogenase family 1 member A2; ALDH1A2; Retinaldehyde-specific dehydrogenase type 2; RALDH(II); EC 1.2.1.36 from Rattus norvegicus (Rat) (see paper)
39% identity, 96% coverage: 19:466/469 of query aligns to 55:511/518 of Q63639
7qk9A Crystal structure of the aldh1a3-atp complex (see paper)
37% identity, 96% coverage: 17:466/469 of query aligns to 28:486/489 of 7qk9A
- binding adenosine-5'-triphosphate: I158 (= I141), T159 (≠ S142), P160 (= P143), W161 (= W144), K185 (= K168), E188 (≠ S171), G218 (≠ E199), G222 (= G203), F236 (= F217), S239 (= S220), V242 (≠ T223)
7a6qB Crystal structure of human aldehyde dehydrogenase 1a3 in complex with selective nr6 inhibitor compound (see paper)
37% identity, 96% coverage: 17:466/469 of query aligns to 29:487/489 of 7a6qB
- active site: N163 (= N145), E262 (= E241), C296 (= C275), E470 (= E449)
- binding nicotinamide-adenine-dinucleotide: I159 (= I141), W162 (= W144), K186 (= K168), E189 (≠ S171), G219 (≠ E199), G223 (= G203), S240 (= S220), V243 (≠ T223), K342 (= K321)
- binding (3-oxidanylidene-3-sodiooxy-propanoyl)oxysodium: A32 (≠ P20), T33 (≠ V21), C34 (≠ I22), P36 (= P24), D103 (≠ E88), E189 (≠ S171), Q190 (≠ F172), F218 (vs. gap), I339 (≠ Q318), D340 (≠ N319)
- binding 3-(2-phenylimidazo[1,2-a]pyridin-6-yl)benzenecarbonitrile: G118 (= G102), D141 (= D123), N143 (≠ S125), N451 (≠ A430), L453 (≠ I432), A455 (≠ P434)
7a6qA Crystal structure of human aldehyde dehydrogenase 1a3 in complex with selective nr6 inhibitor compound (see paper)
37% identity, 96% coverage: 17:466/469 of query aligns to 29:487/489 of 7a6qA
- active site: N163 (= N145), E262 (= E241), C296 (= C275), E470 (= E449)
- binding nicotinamide-adenine-dinucleotide: I159 (= I141), T160 (≠ S142), W162 (= W144), K186 (= K168), A188 (≠ S170), E189 (≠ S171), G219 (≠ E199), G223 (= G203), S240 (= S220), V243 (≠ T223), K342 (= K321), K346 (≠ L325)
- binding 3-(2-phenylimidazo[1,2-a]pyridin-6-yl)benzenecarbonitrile: G118 (= G102), D141 (= D123), N143 (≠ S125), N451 (≠ A430), L453 (≠ I432), Y454 (≠ S433)
5fhzA Human aldehyde dehydrogenase 1a3 complexed with NAD(+) and retinoic acid (see paper)
37% identity, 96% coverage: 17:466/469 of query aligns to 29:487/489 of 5fhzA
- active site: N163 (= N145), K186 (= K168), E262 (= E241), C296 (= C275), E393 (= E372), E470 (= E449)
- binding nicotinamide-adenine-dinucleotide: I159 (= I141), T160 (≠ S142), W162 (= W144), K186 (= K168), E189 (≠ S171), G219 (≠ E199), G223 (= G203), F237 (= F217), G239 (= G219), S240 (= S220), T241 (= T221), V243 (≠ T223), G264 (= G243), Q343 (= Q322), E393 (= E372)
- binding retinoic acid: G118 (= G102), R121 (≠ A105), F164 (= F146), M168 (≠ I150), W171 (= W153), C295 (≠ I274), C296 (= C275), L453 (≠ I432)
P17202 Aminoaldehyde dehydrogenase BADH; 4-trimethylammoniobutyraldehyde dehydrogenase BADH; Aminobutyraldehyde dehydrogenase BADH; Betaine aldehyde dehydrogenase; SoBADH; EC 1.2.1.-; EC 1.2.1.47; EC 1.2.1.19; EC 1.2.1.8 from Spinacia oleracea (Spinach) (see 3 papers)
37% identity, 98% coverage: 5:464/469 of query aligns to 9:482/497 of P17202
- I28 (= I22) binding
- D96 (≠ E88) binding
- SPW 156:158 (= SPW 142:144) binding
- Y160 (≠ F146) mutation to A: Decreases binding affinity for betaine aldehyde; increases binding affinity for 4-(trimethylamino)butanal.
- W167 (= W153) mutation to A: Decreases binding affinity for betaine aldehyde; increases binding affinity for 4-aminobutanal.
- KPSE 182:185 (≠ KPSS 168:171) binding
- L186 (≠ F172) binding
- SSAT 236:239 (≠ STPT 220:223) binding
- V251 (≠ L235) binding in other chain
- L258 (= L242) binding
- W285 (≠ G269) mutation to A: Decreases binding affinity for betaine aldehyde.
- E390 (= E372) binding
- A441 (≠ T423) mutation to I: Decreases binding affinity for betaine aldehyde; increases binding affinity for 4-aminobutanal.
- C450 (≠ I432) mutation to S: Loss of partial inactivation by betaine aldehyde in the absence of NAD(+).
- W456 (≠ F438) binding ; mutation to A: Decreases binding affinity for betaine aldehyde.
- K460 (= K442) binding
P47895 Retinaldehyde dehydrogenase 3; RALDH-3; RalDH3; Aldehyde dehydrogenase 6; Aldehyde dehydrogenase family 1 member A3; ALDH1A3; EC 1.2.1.36 from Homo sapiens (Human) (see 2 papers)
37% identity, 96% coverage: 17:466/469 of query aligns to 47:505/512 of P47895
- R89 (≠ A56) to C: in MCOP8; does not affect ALDH1A3 expression; results in strongly reduced protein levels; dbSNP:rs397514652
- K204 (= K168) binding
- E207 (≠ S171) binding
- GSTEVG 257:262 (≠ GSTPTG 219:224) binding
- Q361 (= Q322) binding
- E411 (= E372) binding
- A493 (≠ G454) to P: in MCOP8; does not affect ALDH1A3 expression; results in strongly reduced protein levels; dbSNP:rs397514653
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 2 modified: N-acetylalanine
4wb9A Human aldh1a1 complexed with nadh (see paper)
38% identity, 96% coverage: 17:466/469 of query aligns to 28:486/493 of 4wb9A
- active site: N162 (= N145), K185 (= K168), E261 (= E241), C295 (= C275), E392 (= E372), E469 (= E449)
- binding 1,4-dihydronicotinamide adenine dinucleotide: I158 (= I141), I159 (≠ S142), P160 (= P143), W161 (= W144), N162 (= N145), K185 (= K168), E188 (≠ S171), G218 (vs. gap), G222 (= G203), F236 (= F217), T237 (= T218), G238 (= G219), S239 (= S220), V242 (≠ T223), G263 (= G243), C295 (= C275), Q342 (= Q322), K345 (≠ L325), E392 (= E372), F394 (= F374)
5teiA Structure of human aldh1a1 with inhibitor cm039
38% identity, 96% coverage: 17:466/469 of query aligns to 28:486/493 of 5teiA
- active site: N162 (= N145), K185 (= K168), E261 (= E241), C295 (= C275), E392 (= E372), E469 (= E449)
- binding 6-{[(3-fluorophenyl)methyl]sulfanyl}-5-(2-methylphenyl)-2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one: S113 (≠ G98), F163 (= F146), H285 (≠ A265), G286 (≠ K266), Y289 (≠ G269), C295 (= C275), G450 (≠ A430), V452 (≠ I432), F458 (= F438)
- binding 1,4-dihydronicotinamide adenine dinucleotide: I158 (= I141), I159 (≠ S142), P160 (= P143), W161 (= W144), N162 (= N145), K185 (= K168), E188 (≠ S171), G218 (≠ V200), G222 (= G203), A223 (≠ R204), F236 (= F217), T237 (= T218), G238 (= G219), S239 (= S220), V242 (≠ T223), C295 (= C275), Q342 (= Q322), K345 (≠ L325), E392 (= E372), F394 (= F374)
4x4lA Structure of human aldh1a1 with inhibitor cm037 (see paper)
38% identity, 96% coverage: 17:466/469 of query aligns to 28:486/493 of 4x4lA
- active site: N162 (= N145), K185 (= K168), E261 (= E241), C295 (= C275), E392 (= E372), E469 (= E449)
- binding ethyl ({4-oxo-3-[3-(pyrrolidin-1-yl)propyl]-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl}sulfanyl)acetate: S113 (≠ G98), M167 (≠ I150), W170 (= W153), Y289 (≠ G269), G450 (≠ A430), F458 (= F438)
- binding 1,4-dihydronicotinamide adenine dinucleotide: I158 (= I141), I159 (≠ S142), P160 (= P143), W161 (= W144), K185 (= K168), E188 (≠ S171), G218 (≠ V200), G222 (= G203), F236 (= F217), T237 (= T218), G238 (= G219), S239 (= S220), V242 (≠ T223), C295 (= C275), Q342 (= Q322), K345 (≠ L325), E392 (= E372), F394 (= F374)
P00352 Aldehyde dehydrogenase 1A1; 3-deoxyglucosone dehydrogenase; ALDH-E1; ALHDII; Aldehyde dehydrogenase family 1 member A1; Aldehyde dehydrogenase, cytosolic; Retinal dehydrogenase 1; RALDH 1; RalDH1; EC 1.2.1.19; EC 1.2.1.28; EC 1.2.1.3; EC 1.2.1.36 from Homo sapiens (Human) (see 7 papers)
38% identity, 96% coverage: 17:466/469 of query aligns to 36:494/501 of P00352
- N121 (≠ G98) to S: in dbSNP:rs1049981
- IPWN 167:170 (≠ SPWN 142:145) binding
- I177 (= I152) to F: in dbSNP:rs8187929
- KPAE 193:196 (≠ KPSS 168:171) binding
- GP 226:227 (≠ VE 200:201) binding
- GS 246:247 (= GS 219:220) binding
- E269 (= E241) active site, Proton acceptor
- ELG 269:271 (= ELG 241:243) binding
- C302 (≠ I274) mutation C->A,S: Does not prevent inhibition by duocarmycin analogs.
- C303 (= C275) active site, Nucleophile
- EQYDK 349:353 (≠ KQFDL 321:325) binding
- EIF 400:402 (≠ EQF 372:374) binding
- G458 (≠ A430) mutation to N: No significant effect on aldehyde dehydrogenase activity. Prevents the inhibition by ALDH1A1-specific inhibitors.
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 2 modified: N-acetylserine
- 336:501 Mediates interaction with PRMT3
7jwwA Crystal structure of human aldh1a1 bound to compound (r)-28 (see paper)
38% identity, 96% coverage: 17:466/469 of query aligns to 29:487/494 of 7jwwA
- active site: N163 (= N145), K186 (= K168), E262 (= E241), C296 (= C275), E393 (= E372), E470 (= E449)
- binding 5-{4-[(Z)-2-hydroxyethenyl]phenyl}-1-methyl-6-{[(1R)-1-phenylethyl]sulfanyl}-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one: G118 (= G102), T122 (≠ W106), F164 (= F146), M168 (≠ I150), Y290 (≠ G269), C295 (≠ I274), C296 (= C275), I297 (≠ A276), V453 (≠ I432), F459 (= F438)
7jwvA Crystal structure of human aldh1a1 bound to compound (r)-28 (see paper)
38% identity, 96% coverage: 17:466/469 of query aligns to 29:487/494 of 7jwvA
- active site: N163 (= N145), K186 (= K168), E262 (= E241), C296 (= C275), E393 (= E372), E470 (= E449)
- binding 5-[4-(hydroxymethyl)phenyl]-1-methyl-6-{[(1R)-1-phenylethyl]sulfanyl}-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one: G118 (= G102), T122 (≠ W106), F164 (= F146), M168 (≠ I150), Y290 (≠ G269), C295 (≠ I274), I297 (≠ A276), V453 (≠ I432), F459 (= F438)
7jwuA Crystal structure of human aldh1a1 bound to compound (r)-28 (see paper)
38% identity, 96% coverage: 17:466/469 of query aligns to 29:487/494 of 7jwuA
- active site: N163 (= N145), K186 (= K168), E262 (= E241), C296 (= C275), E393 (= E372), E470 (= E449)
- binding nicotinamide-adenine-dinucleotide: I159 (= I141), I160 (≠ S142), P161 (= P143), W162 (= W144), N163 (= N145), K186 (= K168), E189 (≠ S171), G219 (vs. gap), G223 (= G203), A224 (≠ R204), F237 (= F217), T238 (= T218), G239 (= G219), S240 (= S220), V243 (≠ T223), L263 (= L242), C296 (= C275), Q343 (= Q322), K346 (≠ L325), E393 (= E372), F395 (= F374)
- binding 1-methyl-5-phenyl-6-{[(1R)-1-(pyridin-2-yl)ethyl]sulfanyl}-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one: T122 (≠ W106), F164 (= F146), W171 (= W153), Y290 (≠ G269), C295 (≠ I274), I297 (≠ A276), V453 (≠ I432), F459 (= F438)
7jwtA Crystal structure of human aldh1a1 bound to compound (r)-28 (see paper)
38% identity, 96% coverage: 17:466/469 of query aligns to 29:487/494 of 7jwtA
- active site: N163 (= N145), K186 (= K168), E262 (= E241), C296 (= C275), E393 (= E372), E470 (= E449)
- binding 6-{[(1R)-1-(3-hydroxyphenyl)ethyl]sulfanyl}-1-methyl-5-phenyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one: G118 (= G102), T122 (≠ W106), F164 (= F146), M168 (≠ I150), W171 (= W153), Y290 (≠ G269), C295 (≠ I274), V453 (≠ I432), F459 (= F438)
Query Sequence
>Ga0059261_1680 Ga0059261_1680 NAD-dependent aldehyde dehydrogenases
VTGVRLIVDGKPLAMAETFPVIDPATGRPFADAPLASTADLDAAVAAARRAFPGWAATPI
EDRAAAILAIADSIEAAKDELARLLSAEQGKPVPNAVGEIMGALAWARATAGLRPAVDVL
KDDDSVRVEVHRKPLGVVASISPWNFPVMIAIWHIIPGLVAGNTVVMKPSSFTPLAALRM
VEIANAHLPPGVLNSVTGEVEIGRAIASHPGIDKIVFTGSTPTGRSIMADGAANLKRLTL
ELGGNDAAIVLPDADVDKVAAKIFAKAFGNSGQICAAVKRVYVHESIHDALAEKLAEMAR
TAVVGPGSDAASQFGPVQNRKQFDLVRALADDARAHGGRFLAGGEAREGDGYFFPLSVVV
DVTDGMRIVDEEQFGPILPVIRYSDPEDALARANANENGLGGSVWSADPAAALAFAQRLE
AGTVWVNDHASISPDVPFGGAKQSGVGTEFGLYGLEEYMQLQTVRVAKN
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory